We enrolled 103 patients with high-risk stage II-III HR+ BC diagnosed more than 5 years prior without clinical evidence of recurrence. We performed whole-exome sequencing (WES) on primary tumor tissue ...
European scientists have announced their success in developing a breakthrough drug that prevents the spread and recurrence of human breast cancer in lab mice, as well as success in human patients ...
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results